Literature DB >> 17307281

A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.

Samia Rourou1, Arno van der Ark, Tiny van der Velden, Héla Kallel.   

Abstract

Rabies virus strain production in Vero cells grown on Cytodex 1 in a 2 L stirred tank bioreactor and in a medium free of components of human or animal origin (VP-SFM) is described. Cell banking procedure in VP-SFM supplemented with an animal components free mixture (10%DMSO+0.1%methylcellulose) was reported and cell growth after revitalization was assessed. Vero cells exhibited growth performances (specific growth rate and cell division number) similar to that obtained in serum containing medium. To design a scalable process that is totally free of animal-derived substances, two proteases: TrypLE Select and Accutase, were assessed as an alternative to trypsin which is routinely used for cell passage. Growth performance of Vero cells grown in VP-SFM and MEM+10% fetal calf serum (FCS) over four passages and subcultivated with either TrypLE Select or Accutase was evaluated. TrypLE Select showed the best performance in terms of specific growth rate and cell division number. Kinetics of cell growth and rabies virus production (LP2061/Vero strain) were investigated in spinner flask and in a 2 L bioreactor. In spinner flask, a maximal cell density level of 1.85x10(6) cells/mL was achieved when the cells were grown in VP-SFM on 2 g/L Cytodex 1. Cell infection experiments conducted at an MOI of 0.3 and without the medium exchange step, typically needed for serum containing rabies virus production, resulted in a maximal virus titer equal to 2x10(7) (Fluorescent Focus Unit) FFU/mL. In stirred tank bioreactor, Vero cell growth in VP-SFM on 3 g/L Cytodex 1 was shown to be sensitive to the aeration mode. Sparging the culture was detrimental for cell growth, whereas cell density level was greatly enhanced when only headspace aeration was used. A cell density level of 2.6x10(6) cells/mL was obtained when the cells were grown on 3g/L Cytodex 1 and in batch culture mode. Cell infection at an MOI of 0.1 without any medium exchange, yielded a maximal rabies virus titer of 2.4x10(7) FFU/mL. Furthermore, Vero cell growth in a 2 L bioreactor using recirculation culture mode during cell proliferation step and perfusion for virus multiplication phase was investigated. In comparison to batch culture, a higher cell density level that was equal to 5x10(6) cells/mL was reached. Cell infection under conditions similar to batch culture, resulted in a maximal virus titer equal to 1.38x10(8) FFU/mL. The potency of the pooled inactivated virus harvests showed an activity of 2.58 IU/mL which was comparable to that obtained in serum supplemented medium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307281     DOI: 10.1016/j.vaccine.2007.01.086

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Real-time monitoring of adherent Vero cell density and apoptosis in bioreactor processes.

Authors:  Emma Petiot; Amal El-Wajgali; Geoffrey Esteban; Cécile Gény; Hervé Pinton; Annie Marc
Journal:  Cytotechnology       Date:  2012-02-25       Impact factor: 2.058

2.  Comparing BRIN-BD11 culture producing insulin using different type of microcarriers.

Authors:  Maizirwan Mel; Mohamed Ismail Abdul Karim; Siti Aisyah Mohd Yusuf; Yumi Zuhanis Has-Yun Hashim; Yusilawati Ahmad Nor
Journal:  Cytotechnology       Date:  2010-10-16       Impact factor: 2.058

Review 3.  Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium.

Authors:  Fumiyuki Hattori; Keiichi Fukuda
Journal:  Exp Mol Med       Date:  2010-03-31       Impact factor: 8.718

4.  Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry.

Authors:  Irina V Gates; Yuhua Zhang; Cindy Shambaugh; Meredith A Bauman; Charles Tan; Jean-Luc Bodmer
Journal:  Appl Environ Microbiol       Date:  2009-02-05       Impact factor: 4.792

5.  Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach.

Authors:  Jianqi Nie; Yang Sun; Fei Han; Yankun Yang; Xiuxia Liu; Chunli Liu; Ye Li; Zhonghu Bai
Journal:  Cytotechnology       Date:  2020-02-21       Impact factor: 2.058

6.  Cell-based influenza vaccine: current production, halal status assessment, and recommendations towards Islamic-compliant manufacturing.

Authors:  Nurul Nadiah Zulkarnain; Nurina Anuar; Norliza Abd Rahman; Siti Rozaimah Sheikh Abdullah; Muhammad Nazir Alias; Mashitoh Yaacob; Zhongren Ma; Gongtao Ding
Journal:  Hum Vaccin Immunother       Date:  2021-02-04       Impact factor: 3.452

7.  Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium.

Authors:  Alan Yung-Chih Hu; Yu-Fen Tseng; Tsai-Chuan Weng; Chien-Chun Liao; Johnson Wu; Ai-Hsiang Chou; Hsin-Ju Chao; Anna Gu; Janice Chen; Su-Chen Lin; Chia-Hsin Hsiao; Suh-Chin Wu; Pele Chong
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

8.  Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.

Authors:  Allen Chen; Swan Li Poh; Christian Dietzsch; Elisabeth Roethl; Mylene L Yan; Say Kong Ng
Journal:  BMC Biotechnol       Date:  2011-08-11       Impact factor: 2.563

Review 9.  Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.

Authors:  Felipe Tapia; Daniel Vázquez-Ramírez; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2016-01-13       Impact factor: 4.813

10.  Assessment of long-term effects of nanoparticles in a microcarrier cell culture system.

Authors:  Maria Mrakovcic; Markus Absenger; Regina Riedl; Claudia Smole; Eva Roblegg; Leopold F Fröhlich; Eleonore Fröhlich
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.